YD

Yagya Duttbhamu

Active Director Director DIN 09679322
DIN 09679322 First appointment Jul 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Yagya Duttbhamu

Data last updated:

Yagya Duttbhamu is a Director at Ragson Pharma Private Limited (since 2022). The company operates in Trading. Ragson Pharma Private Limited reported revenue of ₹4.7 Lakh (FY 2024).

DIN 09679322
Primary Designation Director
Industry Trading
First Appointment 20 Jul 2022
Oldest Company Age 4 yrs
Largest company Ragson Pharma Private Limited · ₹4.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ragson Pharma Private Limited U51909RJ2022PTC082705
Director20 Jul 20222022₹4.7 Lakh (FY 2024)Active

Board colleagues of Yagya Duttbhamu

NameDINCompanyDesignation
Bharti Bhamu09679321Ragson Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ragson Pharma Private Limited
Premium access

Shareholding and investment profile for Yagya Duttbhamu

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yagya Duttbhamu

Yagya Duttbhamu currently holds 1 directorship: Ragson Pharma Private Limited (Director, since 20 Jul 2022, revenue ₹4.7 Lakh (FY 2024)).

Yagya Duttbhamu was first appointed on 20 Jul 2022 as Director at Ragson Pharma Private Limited.

The current boards of Yagya Duttbhamu's companies include Bharti Bhamu (Ragson Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available